Tags

Type your tag names separated by a space and hit enter

Predictive Biomarkers: Understanding Their Use in Treatment Decision Making.
Clin J Oncol Nurs 2019; 23(4):360-363CJ

Abstract

Predictive biomarkers are revolutionizing decisions about colon cancer treatment. Knowing which biomarkers are altered provides valuable information about which treatment may be more effective. DNA mismatch repair and microsatellite instability testing may also identify families that could benefit from further genetic evaluation to determine if there is hereditary risk for colon cancer. Nurses need to be able to explain what these biomarkers mean and how they affect treatment decisions, as well as recommend genetic counseling and testing for hereditary risk when appropriate.

Authors+Show Affiliations

Duke Regional Hospital.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

31322618

Citation

Simonson, Cyndy. "Predictive Biomarkers: Understanding Their Use in Treatment Decision Making." Clinical Journal of Oncology Nursing, vol. 23, no. 4, 2019, pp. 360-363.
Simonson C. Predictive Biomarkers: Understanding Their Use in Treatment Decision Making. Clin J Oncol Nurs. 2019;23(4):360-363.
Simonson, C. (2019). Predictive Biomarkers: Understanding Their Use in Treatment Decision Making. Clinical Journal of Oncology Nursing, 23(4), pp. 360-363. doi:10.1188/19.CJON.360-363.
Simonson C. Predictive Biomarkers: Understanding Their Use in Treatment Decision Making. Clin J Oncol Nurs. 2019 Aug 1;23(4):360-363. PubMed PMID: 31322618.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Predictive Biomarkers: Understanding Their Use in Treatment Decision Making. A1 - Simonson,Cyndy, PY - 2019/7/20/entrez KW - biomarkers KW - colon cancer KW - genetic testing KW - genetics counselor KW - signaling pathways SP - 360 EP - 363 JF - Clinical journal of oncology nursing JO - Clin J Oncol Nurs VL - 23 IS - 4 N2 - Predictive biomarkers are revolutionizing decisions about colon cancer treatment. Knowing which biomarkers are altered provides valuable information about which treatment may be more effective. DNA mismatch repair and microsatellite instability testing may also identify families that could benefit from further genetic evaluation to determine if there is hereditary risk for colon cancer. Nurses need to be able to explain what these biomarkers mean and how they affect treatment decisions, as well as recommend genetic counseling and testing for hereditary risk when appropriate. SN - 1538-067X UR - https://www.unboundmedicine.com/medline/citation/31322618/Predictive_Biomarkers:_Understanding_Their_Use_in_Treatment_Decision_Making L2 - http://store.ons.org/article/find?doi=10.1188/19.CJON.360-363 DB - PRIME DP - Unbound Medicine ER -